Yutaka Niihara, Chairman and CEO at Emmaus Life Sciences, Inc. (EMMA), bought 41,350 shares at $1.51 ($64K) on 2021-11-30, disclosed to the SEC on 2021-12-02.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.51 | 35,600 | $54K | 84.5% |
| 2 | $1.72 | 5,750 | $10K | 15.5% |
| Total | $1.54 avg | 41,350 | $64K | 100% |
| Filing → |
| EMMA | BUY | 2022-10-31 | $19K | — | Filing → |
| EMMA | BUY | 2022-10-24 | $11K | — | Filing → |
| EMMA | BUY | 2022-10-19 | $9K | — | Filing → |